HEADER HYDROLASE/IMMUNE SYSTEM/RNA 29-JUL-20 7JL0 TITLE CRYO-EM STRUCTURE OF MDA5-DSRNA IN COMPLEX WITH TRIM65 PSPRY DOMAIN TITLE 2 (MONOMER) CAVEAT 7JL0 RESIDUES LEU A 1013 AND ASP A 1014 THAT ARE NEXT TO EACH CAVEAT 2 7JL0 OTHER IN THE SAMPLE SEQUENCE ARE NOT PROPERLY LINKED COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA (5'-R(P*GP*AP*CP*UP*GP*AP*CP*UP*GP*AP*CP*UP*GP*A)-3'); COMPND 3 CHAIN: X; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: RNA (5'-R(P*UP*CP*AP*GP*UP*CP*AP*GP*UP*CP*AP*GP*UP*C)-3'); COMPND 7 CHAIN: Y; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: INTERFERON-INDUCED HELICASE C DOMAIN-CONTAINING PROTEIN 1; COMPND 11 CHAIN: A; COMPND 12 FRAGMENT: UNP RESIDUES 287-1025; COMPND 13 SYNONYM: CLINICALLY AMYOPATHIC DERMATOMYOSITIS AUTOANTIGEN 140 KDA, COMPND 14 CADM-140 AUTOANTIGEN,HELICASE WITH 2 CARD DOMAINS,HELICARD, COMPND 15 INTERFERON-INDUCED WITH HELICASE C DOMAIN PROTEIN 1,MELANOMA COMPND 16 DIFFERENTIATION-ASSOCIATED PROTEIN 5,MDA-5,MURABUTIDE DOWN-REGULATED COMPND 17 PROTEIN,RIG-I-LIKE RECEPTOR 2,RLR-2,RNA HELICASE-DEAD BOX PROTEIN COMPND 18 116,IFIH1; COMPND 19 EC: 3.6.4.13; COMPND 20 ENGINEERED: YES; COMPND 21 MOL_ID: 4; COMPND 22 MOLECULE: TRIPARTITE MOTIF-CONTAINING PROTEIN 65; COMPND 23 CHAIN: B; COMPND 24 FRAGMENT: TRIM65 PSPRY DOMAIN (UNP RESIDUES 312-502); COMPND 25 SYNONYM: TRIM65; COMPND 26 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: IFIH1, MDA5, RH116; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 MOL_ID: 4; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 GENE: TRIM65; SOURCE 23 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 24 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INNATE IMMUNITY, UBIQUITIN E3 LIGASE, DSRNA, RNA HELICASE, TRIM KEYWDS 2 FAMILY, HYDROLASE-IMMUNE SYSTEM-RNA COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR K.KATO,S.AHMAD,S.HUR REVDAT 4 06-MAR-24 7JL0 1 REMARK REVDAT 3 17-FEB-21 7JL0 1 JRNL REVDAT 2 20-JAN-21 7JL0 1 JRNL REVDAT 1 09-DEC-20 7JL0 0 JRNL AUTH K.KATO,S.AHMAD,Z.ZHU,J.M.YOUNG,X.MU,S.PARK,H.S.MALIK,S.HUR JRNL TITL STRUCTURAL ANALYSIS OF RIG-I-LIKE RECEPTORS REVEALS ANCIENT JRNL TITL 2 RULES OF ENGAGEMENT BETWEEN DIVERSE RNA HELICASES AND TRIM JRNL TITL 3 UBIQUITIN LIGASES. JRNL REF MOL.CELL V. 81 599 2021 JRNL REFN ISSN 1097-2765 JRNL PMID 33373584 JRNL DOI 10.1016/J.MOLCEL.2020.11.047 REMARK 2 REMARK 2 RESOLUTION. 4.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.300 REMARK 3 NUMBER OF PARTICLES : 49051 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7JL0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1000250985. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : FILAMENT REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : TERNARY COMPLEX OF REMARK 245 MDA5:DSRNA:TRIM65 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : UNSPECIFIED REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 7650.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: X, Y, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 287 REMARK 465 GLY A 288 REMARK 465 SER A 289 REMARK 465 ASP A 290 REMARK 465 SER A 291 REMARK 465 ASP A 292 REMARK 465 GLU A 293 REMARK 465 GLU A 294 REMARK 465 ASN A 295 REMARK 465 VAL A 296 REMARK 465 ALA A 297 REMARK 465 ALA A 298 REMARK 465 ARG A 299 REMARK 465 ALA A 300 REMARK 465 SER A 301 REMARK 465 PRO A 302 REMARK 465 GLU A 303 REMARK 465 PRO A 304 REMARK 465 GLU A 425 REMARK 465 ASN A 426 REMARK 465 GLY A 427 REMARK 465 GLU A 428 REMARK 465 ASP A 429 REMARK 465 GLU A 474 REMARK 465 ASN A 475 REMARK 465 LYS A 476 REMARK 465 PRO A 477 REMARK 465 ALA A 544 REMARK 465 THR A 545 REMARK 465 ASP A 643 REMARK 465 ASP A 644 REMARK 465 SER A 645 REMARK 465 ASP A 646 REMARK 465 GLU A 647 REMARK 465 GLY A 648 REMARK 465 GLY A 649 REMARK 465 ASP A 650 REMARK 465 ASP A 651 REMARK 465 GLU A 652 REMARK 465 TYR A 653 REMARK 465 CYS A 654 REMARK 465 ASP A 655 REMARK 465 GLY A 656 REMARK 465 ASP A 657 REMARK 465 GLU A 658 REMARK 465 ASP A 659 REMARK 465 GLU A 660 REMARK 465 ASP A 661 REMARK 465 ASP A 662 REMARK 465 LEU A 663 REMARK 465 LYS A 664 REMARK 465 LYS A 665 REMARK 465 PRO A 666 REMARK 465 LEU A 667 REMARK 465 LYS A 668 REMARK 465 LEU A 669 REMARK 465 ASP A 670 REMARK 465 HIS A 759 REMARK 465 LYS A 897 REMARK 465 LYS A 945 REMARK 465 THR A 946 REMARK 465 LEU A 947 REMARK 465 GLN A 948 REMARK 465 LYS A 949 REMARK 465 LYS A 950 REMARK 465 CYS A 951 REMARK 465 ALA A 952 REMARK 465 ASP A 953 REMARK 465 TYR A 954 REMARK 465 CYS A 1018 REMARK 465 CYS A 1019 REMARK 465 LEU A 1020 REMARK 465 PHE A 1021 REMARK 465 SER A 1022 REMARK 465 ASP A 1023 REMARK 465 GLU A 1024 REMARK 465 ASP A 1025 REMARK 465 LEU B 312 REMARK 465 ALA B 313 REMARK 465 PRO B 314 REMARK 465 VAL B 315 REMARK 465 PRO B 316 REMARK 465 SER B 317 REMARK 465 THR B 318 REMARK 465 VAL B 319 REMARK 465 CYS B 320 REMARK 465 ALA B 381 REMARK 465 GLY B 382 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 LYS A 473 CG CD CE NZ REMARK 470 LYS A 508 CG CD CE NZ REMARK 470 MET A 570 CG SD CE REMARK 470 GLU A 642 CG CD OE1 OE2 REMARK 470 TYR A 896 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 944 CG CD CE NZ REMARK 470 ARG B 324 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 325 CG CD CE NZ REMARK 470 ARG B 342 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 360 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 403 CG CD OE1 NE2 REMARK 470 ARG B 406 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 409 CG CD1 CD2 REMARK 470 ASP B 430 CG OD1 OD2 REMARK 470 ASN B 437 CG OD1 ND2 REMARK 470 ARG B 442 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 472 CG CD OE1 NE2 REMARK 470 GLN B 502 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O1B ADP A 1102 F1 ALF A 1103 2.12 REMARK 500 NH2 ARG A 822 F3 ALF A 1103 2.16 REMARK 500 O2B ADP A 1102 F3 ALF A 1103 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 354 63.39 62.15 REMARK 500 HIS A 447 1.82 -64.85 REMARK 500 SER A 490 87.99 -161.05 REMARK 500 ASN A 524 55.43 -97.49 REMARK 500 MET A 570 -2.70 68.84 REMARK 500 LYS A 596 -7.87 72.41 REMARK 500 GLU A 716 72.99 61.59 REMARK 500 ALA A 719 119.86 -163.46 REMARK 500 GLU A 762 -153.43 -161.90 REMARK 500 LYS A 764 133.06 -174.89 REMARK 500 GLU A 827 42.30 39.75 REMARK 500 LYS A 925 12.66 54.77 REMARK 500 CYS A 962 -168.86 -77.29 REMARK 500 PRO A1007 12.76 -67.64 REMARK 500 ASP B 430 -60.35 -91.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1101 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 907 SG REMARK 620 2 CYS A 910 SG 90.5 REMARK 620 3 CYS A 962 SG 114.1 116.0 REMARK 620 4 CYS A 964 SG 119.9 85.7 121.1 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-22368 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-22370 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-22369 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-22371 RELATED DB: EMDB DBREF 7JL0 X 1 14 PDB 7JL0 7JL0 1 14 DBREF 7JL0 Y 1 14 PDB 7JL0 7JL0 1 14 DBREF 7JL0 A 287 1025 UNP Q9BYX4 IFIH1_HUMAN 287 1025 DBREF 7JL0 B 312 502 UNP Q6PJ69 TRI65_HUMAN 312 502 SEQADV 7JL0 ARG A 843 UNP Q9BYX4 HIS 843 CONFLICT SEQADV 7JL0 LYS A 944 UNP Q9BYX4 ASN 944 CONFLICT SEQADV 7JL0 THR A 946 UNP Q9BYX4 ALA 946 CONFLICT SEQADV 7JL0 LEU B 356 UNP Q6PJ69 CYS 356 CONFLICT SEQADV 7JL0 SER B 407 UNP Q6PJ69 CYS 407 CONFLICT SEQADV 7JL0 SER B 421 UNP Q6PJ69 CYS 421 CONFLICT SEQRES 1 X 14 G A C U G A C U G A C U G SEQRES 2 X 14 A SEQRES 1 Y 14 U C A G U C A G U C A G U SEQRES 2 Y 14 C SEQRES 1 A 739 MET GLY SER ASP SER ASP GLU GLU ASN VAL ALA ALA ARG SEQRES 2 A 739 ALA SER PRO GLU PRO GLU LEU GLN LEU ARG PRO TYR GLN SEQRES 3 A 739 MET GLU VAL ALA GLN PRO ALA LEU GLU GLY LYS ASN ILE SEQRES 4 A 739 ILE ILE CYS LEU PRO THR GLY SER GLY LYS THR ARG VAL SEQRES 5 A 739 ALA VAL TYR ILE ALA LYS ASP HIS LEU ASP LYS LYS LYS SEQRES 6 A 739 LYS ALA SER GLU PRO GLY LYS VAL ILE VAL LEU VAL ASN SEQRES 7 A 739 LYS VAL LEU LEU VAL GLU GLN LEU PHE ARG LYS GLU PHE SEQRES 8 A 739 GLN PRO PHE LEU LYS LYS TRP TYR ARG VAL ILE GLY LEU SEQRES 9 A 739 SER GLY ASP THR GLN LEU LYS ILE SER PHE PRO GLU VAL SEQRES 10 A 739 VAL LYS SER CYS ASP ILE ILE ILE SER THR ALA GLN ILE SEQRES 11 A 739 LEU GLU ASN SER LEU LEU ASN LEU GLU ASN GLY GLU ASP SEQRES 12 A 739 ALA GLY VAL GLN LEU SER ASP PHE SER LEU ILE ILE ILE SEQRES 13 A 739 ASP GLU CYS HIS HIS THR ASN LYS GLU ALA VAL TYR ASN SEQRES 14 A 739 ASN ILE MET ARG HIS TYR LEU MET GLN LYS LEU LYS ASN SEQRES 15 A 739 ASN ARG LEU LYS LYS GLU ASN LYS PRO VAL ILE PRO LEU SEQRES 16 A 739 PRO GLN ILE LEU GLY LEU THR ALA SER PRO GLY VAL GLY SEQRES 17 A 739 GLY ALA THR LYS GLN ALA LYS ALA GLU GLU HIS ILE LEU SEQRES 18 A 739 LYS LEU CYS ALA ASN LEU ASP ALA PHE THR ILE LYS THR SEQRES 19 A 739 VAL LYS GLU ASN LEU ASP GLN LEU LYS ASN GLN ILE GLN SEQRES 20 A 739 GLU PRO CYS LYS LYS PHE ALA ILE ALA ASP ALA THR ARG SEQRES 21 A 739 GLU ASP PRO PHE LYS GLU LYS LEU LEU GLU ILE MET THR SEQRES 22 A 739 ARG ILE GLN THR TYR CYS GLN MET SER PRO MET SER ASP SEQRES 23 A 739 PHE GLY THR GLN PRO TYR GLU GLN TRP ALA ILE GLN MET SEQRES 24 A 739 GLU LYS LYS ALA ALA LYS GLU GLY ASN ARG LYS GLU ARG SEQRES 25 A 739 VAL CYS ALA GLU HIS LEU ARG LYS TYR ASN GLU ALA LEU SEQRES 26 A 739 GLN ILE ASN ASP THR ILE ARG MET ILE ASP ALA TYR THR SEQRES 27 A 739 HIS LEU GLU THR PHE TYR ASN GLU GLU LYS ASP LYS LYS SEQRES 28 A 739 PHE ALA VAL ILE GLU ASP ASP SER ASP GLU GLY GLY ASP SEQRES 29 A 739 ASP GLU TYR CYS ASP GLY ASP GLU ASP GLU ASP ASP LEU SEQRES 30 A 739 LYS LYS PRO LEU LYS LEU ASP GLU THR ASP ARG PHE LEU SEQRES 31 A 739 MET THR LEU PHE PHE GLU ASN ASN LYS MET LEU LYS ARG SEQRES 32 A 739 LEU ALA GLU ASN PRO GLU TYR GLU ASN GLU LYS LEU THR SEQRES 33 A 739 LYS LEU ARG ASN THR ILE MET GLU GLN TYR THR ARG THR SEQRES 34 A 739 GLU GLU SER ALA ARG GLY ILE ILE PHE THR LYS THR ARG SEQRES 35 A 739 GLN SER ALA TYR ALA LEU SER GLN TRP ILE THR GLU ASN SEQRES 36 A 739 GLU LYS PHE ALA GLU VAL GLY VAL LYS ALA HIS HIS LEU SEQRES 37 A 739 ILE GLY ALA GLY HIS SER SER GLU PHE LYS PRO MET THR SEQRES 38 A 739 GLN ASN GLU GLN LYS GLU VAL ILE SER LYS PHE ARG THR SEQRES 39 A 739 GLY LYS ILE ASN LEU LEU ILE ALA THR THR VAL ALA GLU SEQRES 40 A 739 GLU GLY LEU ASP ILE LYS GLU CYS ASN ILE VAL ILE ARG SEQRES 41 A 739 TYR GLY LEU VAL THR ASN GLU ILE ALA MET VAL GLN ALA SEQRES 42 A 739 ARG GLY ARG ALA ARG ALA ASP GLU SER THR TYR VAL LEU SEQRES 43 A 739 VAL ALA HIS SER GLY SER GLY VAL ILE GLU ARG GLU THR SEQRES 44 A 739 VAL ASN ASP PHE ARG GLU LYS MET MET TYR LYS ALA ILE SEQRES 45 A 739 HIS CYS VAL GLN ASN MET LYS PRO GLU GLU TYR ALA HIS SEQRES 46 A 739 LYS ILE LEU GLU LEU GLN MET GLN SER ILE MET GLU LYS SEQRES 47 A 739 LYS MET LYS THR LYS ARG ASN ILE ALA LYS HIS TYR LYS SEQRES 48 A 739 ASN ASN PRO SER LEU ILE THR PHE LEU CYS LYS ASN CYS SEQRES 49 A 739 SER VAL LEU ALA CYS SER GLY GLU ASP ILE HIS VAL ILE SEQRES 50 A 739 GLU LYS MET HIS HIS VAL ASN MET THR PRO GLU PHE LYS SEQRES 51 A 739 GLU LEU TYR ILE VAL ARG GLU LYS LYS THR LEU GLN LYS SEQRES 52 A 739 LYS CYS ALA ASP TYR GLN ILE ASN GLY GLU ILE ILE CYS SEQRES 53 A 739 LYS CYS GLY GLN ALA TRP GLY THR MET MET VAL HIS LYS SEQRES 54 A 739 GLY LEU ASP LEU PRO CYS LEU LYS ILE ARG ASN PHE VAL SEQRES 55 A 739 VAL VAL PHE LYS ASN ASN SER THR LYS LYS GLN TYR LYS SEQRES 56 A 739 LYS TRP VAL GLU LEU PRO ILE THR PHE PRO ASN LEU ASP SEQRES 57 A 739 TYR SER GLU CYS CYS LEU PHE SER ASP GLU ASP SEQRES 1 B 191 LEU ALA PRO VAL PRO SER THR VAL CYS PRO LEU ARG ARG SEQRES 2 B 191 LYS LEU TRP GLN ASN TYR ARG ASN LEU THR PHE ASP PRO SEQRES 3 B 191 VAL SER ALA ASN ARG HIS PHE TYR LEU SER ARG GLN ASP SEQRES 4 B 191 GLN GLN VAL LYS HIS LEU ARG GLN SER ARG GLY PRO GLY SEQRES 5 B 191 GLY PRO GLY SER PHE GLU LEU TRP GLN VAL GLN CYS ALA SEQRES 6 B 191 GLN SER PHE GLN ALA GLY HIS HIS TYR TRP GLU VAL ARG SEQRES 7 B 191 ALA SER ASP HIS SER VAL THR LEU GLY VAL SER TYR PRO SEQRES 8 B 191 GLN LEU PRO ARG SER ARG LEU GLY PRO HIS THR ASP ASN SEQRES 9 B 191 ILE GLY ARG GLY PRO SER SER TRP GLY LEU CYS VAL GLN SEQRES 10 B 191 GLU ASP SER LEU GLN ALA TRP HIS ASN GLY GLU ALA GLN SEQRES 11 B 191 ARG LEU PRO GLY VAL SER GLY ARG LEU LEU GLY MET ASP SEQRES 12 B 191 LEU ASP LEU ALA SER GLY CYS LEU THR PHE TYR SER LEU SEQRES 13 B 191 GLU PRO GLN THR GLN PRO LEU TYR THR PHE HIS ALA LEU SEQRES 14 B 191 PHE ASN GLN PRO LEU THR PRO VAL PHE TRP LEU LEU GLU SEQRES 15 B 191 GLY ARG THR LEU THR LEU CYS HIS GLN HET ZN A1101 1 HET ADP A1102 27 HET ALF A1103 5 HET MG A1104 1 HETNAM ZN ZINC ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM ALF TETRAFLUOROALUMINATE ION HETNAM MG MAGNESIUM ION FORMUL 5 ZN ZN 2+ FORMUL 6 ADP C10 H15 N5 O10 P2 FORMUL 7 ALF AL F4 1- FORMUL 8 MG MG 2+ HELIX 1 AA1 ARG A 309 GLN A 317 1 9 HELIX 2 AA2 PRO A 318 GLU A 321 5 4 HELIX 3 AA3 GLY A 334 ALA A 353 1 20 HELIX 4 AA4 LYS A 365 LYS A 375 1 11 HELIX 5 AA5 GLU A 376 LEU A 381 1 6 HELIX 6 AA6 SER A 399 CYS A 407 1 9 HELIX 7 AA7 ALA A 414 LEU A 422 1 9 HELIX 8 AA8 CYS A 445 THR A 448 5 4 HELIX 9 AA9 ALA A 452 LYS A 472 1 21 HELIX 10 AB1 LYS A 498 ASP A 514 1 17 HELIX 11 AB2 ASN A 524 ILE A 532 1 9 HELIX 12 AB3 ASP A 548 GLN A 566 1 19 HELIX 13 AB4 THR A 575 GLY A 593 1 19 HELIX 14 AB5 GLU A 597 ILE A 617 1 21 HELIX 15 AB6 ARG A 618 VAL A 640 1 23 HELIX 16 AB7 ASP A 673 GLU A 692 1 20 HELIX 17 AB8 GLU A 699 GLU A 716 1 18 HELIX 18 AB9 THR A 727 ASN A 741 1 15 HELIX 19 AC1 GLU A 742 VAL A 747 1 6 HELIX 20 AC2 THR A 767 GLY A 781 1 15 HELIX 21 AC3 THR A 790 GLU A 793 5 4 HELIX 22 AC4 GLU A 813 ARG A 822 1 10 HELIX 23 AC5 VAL A 840 GLN A 862 1 23 HELIX 24 AC6 LYS A 865 HIS A 895 1 31 HELIX 25 AC7 PRO A 933 TYR A 939 1 7 HELIX 26 AC8 LYS A 983 ARG A 985 5 3 HELIX 27 AC9 LEU B 322 TRP B 327 1 6 HELIX 28 AD1 GLN B 328 TYR B 330 5 3 SHEET 1 AA1 6 ILE A 325 CYS A 328 0 SHEET 2 AA1 6 GLN A 483 THR A 488 1 O THR A 488 N ILE A 327 SHEET 3 AA1 6 LEU A 439 ASP A 443 1 N ILE A 440 O LEU A 485 SHEET 4 AA1 6 VAL A 359 VAL A 363 1 N LEU A 362 O ILE A 441 SHEET 5 AA1 6 ILE A 409 THR A 413 1 O ILE A 410 N VAL A 361 SHEET 6 AA1 6 VAL A 387 GLY A 389 1 N ILE A 388 O ILE A 409 SHEET 1 AA2 6 CYS A 536 ILE A 541 0 SHEET 2 AA2 6 THR A 829 ALA A 834 1 O LEU A 832 N ALA A 540 SHEET 3 AA2 6 ILE A 803 TYR A 807 1 N VAL A 804 O THR A 829 SHEET 4 AA2 6 GLY A 721 PHE A 724 1 N PHE A 724 O ILE A 805 SHEET 5 AA2 6 LEU A 785 ALA A 788 1 O ALA A 788 N ILE A 723 SHEET 6 AA2 6 ALA A 751 LEU A 754 1 N LEU A 754 O ILE A 787 SHEET 1 AA3 3 LEU A 913 SER A 916 0 SHEET 2 AA3 3 THR A 904 CYS A 907 -1 N PHE A 905 O CYS A 915 SHEET 3 AA3 3 PHE A 987 VAL A 990 -1 O VAL A 988 N LEU A 906 SHEET 1 AA4 2 ILE A 920 ILE A 923 0 SHEET 2 AA4 2 HIS A 927 ASN A 930 -1 O VAL A 929 N HIS A 921 SHEET 1 AA5 4 ILE A 940 ARG A 942 0 SHEET 2 AA5 4 GLU A 959 ILE A 961 -1 O ILE A 961 N ILE A 940 SHEET 3 AA5 4 ALA A 967 HIS A 974 -1 O GLY A 969 N ILE A 960 SHEET 4 AA5 4 LEU A 977 PRO A 980 -1 O LEU A 977 N HIS A 974 SHEET 1 AA6 7 PHE B 344 SER B 347 0 SHEET 2 AA6 7 GLN B 352 HIS B 355 -1 O LYS B 354 N TYR B 345 SHEET 3 AA6 7 THR B 496 LEU B 499 -1 O LEU B 497 N VAL B 353 SHEET 4 AA6 7 HIS B 384 ALA B 390 -1 N ARG B 389 O THR B 498 SHEET 5 AA6 7 LEU B 451 ASP B 456 -1 O LEU B 451 N VAL B 388 SHEET 6 AA6 7 CYS B 461 SER B 466 -1 O TYR B 465 N GLY B 452 SHEET 7 AA6 7 GLN B 472 HIS B 478 -1 O TYR B 475 N PHE B 464 SHEET 1 AA7 6 GLN B 372 GLN B 374 0 SHEET 2 AA7 6 THR B 486 TRP B 490 -1 O PHE B 489 N VAL B 373 SHEET 3 AA7 6 VAL B 395 SER B 400 -1 N GLY B 398 O VAL B 488 SHEET 4 AA7 6 SER B 422 VAL B 427 -1 O VAL B 427 N VAL B 395 SHEET 5 AA7 6 SER B 431 TRP B 435 -1 O GLN B 433 N CYS B 426 SHEET 6 AA7 6 ARG B 442 PRO B 444 -1 O LEU B 443 N LEU B 432 LINK SG CYS A 907 ZN ZN A1101 1555 1555 2.32 LINK SG CYS A 910 ZN ZN A1101 1555 1555 2.30 LINK SG CYS A 962 ZN ZN A1101 1555 1555 2.34 LINK SG CYS A 964 ZN ZN A1101 1555 1555 2.32 LINK O1B ADP A1102 MG MG A1104 1555 1555 2.60 CISPEP 1 GLU B 468 PRO B 469 0 -3.59 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000